Zavat

The Stephens Group Exits CoreLink

Retrieved on: 
Tuesday, June 27, 2023
Professional Services, Health, Medical Devices, Surgery, Venture Capital, General Health, Biotechnology, Mimesis, Zavat, Stephens Inc., Acquisition, Cerberus Capital Management, Sale

The Stephens Group, LLC (“The Stephens Group”) is pleased to announce the exit of CoreLink, LLC (“CoreLink” or the “Company”) through a sale of the business to Zavation Medical Products (“Zavation”), a portfolio company of Gemspring Capital Management, LLC (“Gemspring”).

Key Points: 
  • The Stephens Group, LLC (“The Stephens Group”) is pleased to announce the exit of CoreLink, LLC (“CoreLink” or the “Company”) through a sale of the business to Zavation Medical Products (“Zavation”), a portfolio company of Gemspring Capital Management, LLC (“Gemspring”).
  • Zavation and CoreLink will continue to operate under their respective brands and the combined business will be led by Zavation CEO Jeffrey Johnson, while Jay Bartling, CEO of CoreLink, will become Chairman of the Board of Directors.
  • The Stephens Group will retain a minority stake in the combined entity.
  • “We congratulate Jay and the entire CoreLink team on this well-earned milestone,” said Grant Jones, Managing Director at The Stephens Group.

Zavation Medical Products, LLC, receives FDA 510K Clearance for Varisync™ Anterior Cervical Plate and Spacer system as an addition to its cervical spine portfolio

Retrieved on: 
Thursday, August 18, 2022
FDA, Multimedia, Degenerative disc disease, Fracture, Spondylolisthesis, Surgeon, MS, Neck pain, Nonunion, LLC, Trauma, Research, History, The Company, Neoplasm, Patient, Company, Kyphosis, View, Genesis Revisited II, Lordosis, Spinal stenosis, Deformity, Medicine, MIS, Scoliosis, DDD, Medical device, Dentistry, Medical imaging, Zavat

Zavation Medical Products, LLC, receives FDA 510K Clearance for Varisync Anterior Cervical Plate and Spacer system as an addition to its cervical spine portfolio.

Key Points: 
  • Zavation Medical Products, LLC, receives FDA 510K Clearance for Varisync Anterior Cervical Plate and Spacer system as an addition to its cervical spine portfolio.
  • Varisync, the most recent addition to the Zavation cervical spine portfolio, has been tested and approved for both the independent and synchronized use of its plate and spacer components.
  • This allows Zavation's surgeon partners to use these plate and spacer options together as a system or pair individual components with any of Zavation's existing cervical portfolio options.
  • These devices are intended to be used with supplemental fixation such as the Zavation VariSyncPlate, Zavation Midline Plate, Zavation EZ Plate, or Zavation Cervical Plate Systems.

Zavation releases In-Vitro and In-Vivo Research Summary for its novel "LABYRINTH™"

Retrieved on: 
Wednesday, August 10, 2022
Multimedia, Surgeon, MS, Technology, Patent, Wetting, Research, Nonunion, Surgery, Company, Titanium, Evaluation, View, PEEK, MIS, Labyrinth, Innovation, 3D printing, Zavat

In creating the first fully porous PEEK interbody, Zavation has enhanced the benefits of PEEK (reduced stress shielding and artifact-free imaging) with substantially improved wettability and surface tension.

Key Points: 
  • In creating the first fully porous PEEK interbody, Zavation has enhanced the benefits of PEEK (reduced stress shielding and artifact-free imaging) with substantially improved wettability and surface tension.
  • stated, "The Zavation Labyrinth cervical interbody allows bony ingrowth THROUGH the interbody instead of only the central window while also incorporating the peripheral structure of the cage.
  • Founded in 2012, Zavation has experienced exceptional growth and created a national network of numerous distributors across the UnitedStates.
  • Zavation operates a newly constructed 75,000 square foot vertically integrated facility inFlowood, MS. To learn more information about Zavation and the Company's suite of products, visit www.zavation.com .

Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand™ Lateral Cage as an addition to its eZspand™ Interbody System.

Retrieved on: 
Friday, June 10, 2022
MIS, Company, Research, Degenerative disc disease, Back pain, Lateral, Multimedia, DDD, FDA, Patient, MS, History, Surgeon, View, Lordosis, Medical device, Dentistry, S1, Zavat

The eZspand Lateral, part of the Zavation eZspand Interbody System, features unmatched expandable precision paired with continual expansion to provide an optimized fit for each patient.

Key Points: 
  • The eZspand Lateral, part of the Zavation eZspand Interbody System, features unmatched expandable precision paired with continual expansion to provide an optimized fit for each patient.
  • The benefits of continuous height adjustment, up to 6mm expansion paired with no secondary locking step, separate eZspand Lateral from its competitors.
  • The Zavation eZspand Interbody System implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients.
  • The Zavation eZspand Interbody System implants are intended to be used with supplemental internal fixation appropriate for the implanted level, including the Zavation Spinal System.